Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease

Cheng Yin Yuan, Vivian Zhou, Garrett Sauber, Todd Stollenwerk, Richard Komorowski, Alicia López, Rosa María Tolón, Julian Romero, Cecilia J. Hillard, William R. Drobyski

Blood (2021) 137 (9): 1241–1255.

https://doi.org/10.1182/blood.2020004871

Published: 2021

Includes: Supplemental data

Journal Articles

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Christopher M Melén, MD, Magali Merrien, MSc, Agata Wasik, MSc, PhD, Kristina Sonnevi, MD PhD, Henna-Riikka Junlén, MD, Birger Christersson, MD PhD, Birgitta Sander, MD PhD Prof., Björn E Wahlin, MD PhD

Blood (2019) 134 (Supplement_1): 5487.

https://doi.org/10.1182/blood-2019-126693

Published: 2019

Journal Articles

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Alison Moe, PhD, Garrett Sauber, BS, Vivian Zhou, PhD, Anissa Lapitz, BS, Cecilia Hillard, PhD, William R. Drobyski, MD

Blood (2019) 134 (Supplement_1): 195.

https://doi.org/10.1182/blood-2019-122746

Published: 2019

Journal Articles

Cannabinoid Receptors and CXCR4 Cross-Talk in Lymphoma Cells

Magali Merrien, MSc, Agata Magdalena Wasik, PhD MSc, Christopher Melén, MD, Kristina Sonnevi, MD PhD, Birger Christensson, MD PhD, Björn E Wahlin, Birgitta Sander, MD PhD

Blood (2018) 132 (Supplement 1): 4121.

https://doi.org/10.1182/blood-2018-99-112096

Published: 2018

Journal Articles

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Lan Pham, PhD, Juan Chen, PhD, Archie Tamayo, MS, Jerry Bryant, David Yang, PhD, Richard J. Ford, Jr., MD PhD

Blood (2016) 128 (22): 4181.

https://doi.org/10.1182/blood.V128.22.4181.4181

Published: 2016

Journal Articles

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Mayte Medrano, María Victoria Barbado-Gonzalez, Nuria Campillo, Francisco Hidalgo, Teresa Caballero-Velazquez, Olga Perez-Lopez, Maria Sole-Rodriguez, Jose Ignacio Piruat-Palomo, Jose A. Perez-Simon, MD, PhD

Blood (2016) 128 (22): 4718.

https://doi.org/10.1182/blood.V128.22.4718.4718

Published: 2016

Journal Articles

Epigenetic Upregulation of the O-Linked Beta-N-Acetylglucosamine Transferase (OGT) in Response to Dronabinol Results in Antileukemic Efficacy In Vivo

Kerstin Maria Kampa-Schittenhelm, MD, Hans-Joerg Buehring, Michael Bonin, Wichard Vogel, MD, Lothar Kanz, Prof. Dr. MD, Thomas Haverkamp, Marcus M Schittenhelm, MD

Blood (2015) 126 (23): 2437.

https://doi.org/10.1182/blood.V126.23.2437.2437

Published: 2015

Journal Articles

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Patricia Weiss, Edit Anna Porpaczy, MD, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich Jäger, Katrina Vanura

Blood (2012) 120 (21): 4565.

https://doi.org/10.1182/blood.V120.21.4565.4565

Published: 2012

Journal Articles

Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression

Sabina Adhikary, Virginia P. Kocieda, Jui-Hung Yen, Ronald F. Tuma, Doina Ganea

Blood (2012) 120 (18): 3741–3749.

https://doi.org/10.1182/blood-2012-06-435362

Published: 2012

Includes: Supplemental data

Journal Articles

Warfarin Untargeted Metabolomics Study Identifies Novel Procoagulant Ethanolamide Lipids

Hiroshi Deguchi, MD, PhD, Sunia Trauger, PhD, Ewa Kalisiak, PhD, Hui-Min Zhang, PhD, Gary Siuzdak, PhD, John H. Griffin, PhD, Darlene J Elias, MD

Blood (2011) 118 (21): 1200.

https://doi.org/10.1182/blood.V118.21.1200.1200

Published: 2011

Journal Articles

Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood . 2011;117(3): 827–838 .

Blood (2011) 118 (7): 2027.

https://doi.org/10.1182/blood-2011-06-363325

Published: 2011

Journal Articles

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization

Shuxian Jiang, Meritxell Alberich-Jorda, Radoslaw Zagozdzon, Kalindi Parmar, Yigong Fu, Peter Mauch, Naheed Banu, Alexandros Makriyannis, Daniel G. Tenen, Shalom Avraham, Jerome E. Groopman, Hava Karsenty Avraham

Blood (2011) 117 (3): 827–838.

https://doi.org/10.1182/blood-2010-01-265082

Published: 2011

Includes: Supplemental data

Journal Articles

Cannabinoid Receptors CB1 and CB2 Regulate Mobilization of Hematopoietic Stem and Progenitor Cells.

Hava Avraham, PhD, Radoslaw Zagozdzon, MD, PhD, Yigong Fu, MS, Jerome E. Groopman, MD, Shuxian Jiang, PhD

Blood (2008) 112 (11): 1383.

https://doi.org/10.1182/blood.V112.11.1383.1383

Published: 2008

Journal Articles

Activated Protein C Inhibits Lipopolysaccharide-Induced Anandamide and 2-Arachidonoylglycerol Generation In Vitro and In Vivo .

Ikuro Maruyama, Yin Wang, Yan Liu, Koichi Kawahara, Munekazu Yamakuchi, Teruto Hashiguchi, Toru Obata

Blood (2007) 110 (11): 1754.

https://doi.org/10.1182/blood.V110.11.1754.1754

Published: 2007

Journal Articles

The Endocannabinoid 2-Arachidonoylglycerol Regulates Platelet Function.

Samantha Baldassarri, Alessandra Bertoni, Paolo Lova, Stefania Reineri, Chiara Sarasso, Manuela Zanfa, Elena Sanna, Mauro Maccarrone, Mauro Torti, Fabiola Sinigaglia

Blood (2006) 108 (11): 3904.

https://doi.org/10.1182/blood.V108.11.3904.3904

Published: 2006

Journal Articles

Endogenous Cannabinoid-Like Arachidonoyl Serine Protects Against LPS-Induced Endothelial Apoptosis.

Xuefeng Zhang, MD, PhD, Jian Feng Wang, M.D., Ph.D., Yehoshua Maor, Ph.D., George Kunos, M.D., Ph.D., Jerome E. Groopman, M.D.

Blood (2006) 108 (11): 1808.

https://doi.org/10.1182/blood.V108.11.1808.1808

Published: 2006

Journal Articles

The Potential Role of Delta(9)-Tetrahydrocannabinol in the Pathogenesis of Kaposi’s Sarcoma.

Xuefeng Zhang, MD, PhD, Jian Feng Wang, MD, PhD, George Kunos, MD, PhD, Jerome E. Groopman, MD

Blood (2005) 106 (11): 1429.

https://doi.org/10.1182/blood.V106.11.1429.1429

Published: 2005

Journal Articles

Quantitative RT-PCR Assessment of Cannabinoid Receptor CB2 and Fatty Acid Amine Hydrolase in Neoplastic Cells of Patients with B-Cell Chronic Lymphocytic Leukaemia.

Jaroslaw A. Piszcz, MD, PhD, Janusz S. Kloczko, MD, PhD, Slawomir Ziarko, MSc, Piotr Radziwon, MD, PhD, Katarzyna Z. Mazgajska-Barczyk, MD, PhD

Blood (2005) 106 (11): 4995.

https://doi.org/10.1182/blood.V106.11.4995.4995

Published: 2005

Journal Articles

Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways.

Xuefeng Zhang, MD, PhD, Jian Feng Wang, MD, PhD, Yehoshua Maor, PhD, George Kunos, MD, PhD, Jerome E. Groopman, MD

Blood (2005) 106 (11): 3690.

https://doi.org/10.1182/blood.V106.11.3690.3690

Published: 2005

Journal Articles

Molecular Characterization of the Cannabinoid-Mediated Migration of Monocytes.

In-Woo Park, PhD, Appakkudal R. Anand, PhD, Jerome E. Groopman, MD

Blood (2005) 106 (11): 3878.

https://doi.org/10.1182/blood.V106.11.3878.3878

Published: 2005

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Cannabinoid Receptors and CXCR4 Cross-Talk in Lymphoma Cells

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Epigenetic Upregulation of the O-Linked Beta-N-Acetylglucosamine Transferase (OGT) in Response to Dronabinol Results in Antileukemic Efficacy In Vivo

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression

Warfarin Untargeted Metabolomics Study Identifies Novel Procoagulant Ethanolamide Lipids

Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood . 2011;117(3): 827–838 .

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization

Cannabinoid Receptors CB1 and CB2 Regulate Mobilization of Hematopoietic Stem and Progenitor Cells.

Activated Protein C Inhibits Lipopolysaccharide-Induced Anandamide and 2-Arachidonoylglycerol Generation In Vitro and In Vivo .

The Endocannabinoid 2-Arachidonoylglycerol Regulates Platelet Function.

Endogenous Cannabinoid-Like Arachidonoyl Serine Protects Against LPS-Induced Endothelial Apoptosis.

The Potential Role of Delta(9)-Tetrahydrocannabinol in the Pathogenesis of Kaposi’s Sarcoma.

Quantitative RT-PCR Assessment of Cannabinoid Receptor CB2 and Fatty Acid Amine Hydrolase in Neoplastic Cells of Patients with B-Cell Chronic Lymphocytic Leukaemia.

Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways.

Molecular Characterization of the Cannabinoid-Mediated Migration of Monocytes.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only